Highlights

Share

Program Content

Activities

CARISEL Clinical Outcomes
CARISEL: Clinical Outcomes by Implementation Strategy of Patients Receiving LA CAB + RPV in European Healthcare Settings
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 26, 2022

PrEP Survey in US Women
Survey of PrEP Interest, Usage, and Awareness Among US Cisgender Women
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 26, 2022

HPTN 083 Update
HPTN 083: HIV Infections in the Yr 1 Unblinded Period in MSM and TGW Receiving Injectable CAB for HIV PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 27, 2022

Factors Associated With Virologic Failure in LA ART
ATLAS, ATLAS-2M, and FLAIR Pooled Analysis: Factors Associated With Virologic Failure in PWH Receiving LA CAB + RPV Using Expanded Multivariable Models
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 28, 2022

Optimal ISL Daily Dose
Selection of Optimal Islatravir Doses for Persons With HIV Naive to Treatment and Switching From Stable Therapy Through Modeling and Simulation
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 01, 2022

OPERA: Real-world LA CAB + RPV
Real-world Effectiveness of Long-Acting CAB + RPV in the First Yr in the US OPERA Cohort
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 01, 2022

CAPELLA: LEN in MDR HIV
CAPELLA: Wk 52 Results With Long-Acting SC Lenacapavir in Randomized and Nonrandomized Cohorts of Persons With Multidrug-Resistant HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2022

BANNER Study
BANNER Study: Broadly Neutralizing Antibody VH3810109 in People With HIV Naive to Treatment
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 04, 2022

BICSTaR: BIC/FTC/TAF Effectiveness
BICSTaR: BIC/FTC/TAF Effectiveness and Safety by Demographics and Baseline Characteristics at 24 Mo
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2022

Islatravir Lymphocyte Changes
Protocol 011: Post Hoc Analysis of Lymphocyte Changes in PWH Receiving Islatravir
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2022

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare